Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


A web application for evaluating Phase I methods using a non-parametric optimal benchmark.

Wages NA, Varhegyi N.

Clin Trials. 2017 Oct;14(5):553-557. doi: 10.1177/1740774517715456. Epub 2017 Jun 24.


A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma.

Dillon PM, Petroni GR, Horton BJ, Moskaluk CA, Fracasso PM, Douvas MG, Varhegyi N, Zaja-Milatovic S, Thomas CY.

Clin Cancer Res. 2017 Aug 1;23(15):4138-4145. doi: 10.1158/1078-0432.CCR-16-2942. Epub 2017 Apr 4.


A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites.

Slingluff CL Jr, Petroni GR, Olson WC, Smolkin ME, Chianese-Bullock KA, Mauldin IS, Smith KT, Deacon DH, Varhegyi NE, Donnelly SB, Reed CM, Scott K, Galeassi NV, Grosh WW.

Cancer Immunol Immunother. 2016 Jan;65(1):25-36. doi: 10.1007/s00262-015-1770-9. Epub 2015 Nov 18.


An interprofessional workshop for students to improve communication and collaboration skills in end-of-life care.

Erickson JM, Blackhall L, Brashers V, Varhegyi N.

Am J Hosp Palliat Care. 2015 Dec;32(8):876-80. doi: 10.1177/1049909114549954. Epub 2014 Aug 29.


Impact of blood transfusions on patients with head and neck cancer undergoing free tissue transfer.

Danan D, Smolkin ME, Varhegyi NE, Bakos SR, Jameson MJ, Shonka DC Jr.

Laryngoscope. 2015 Jan;125(1):86-91. doi: 10.1002/lary.24847. Epub 2014 Aug 14.


pocrm: an R-package for phase I trials of combinations of agents.

Wages NA, Varhegyi N.

Comput Methods Programs Biomed. 2013 Oct;112(1):211-8. doi: 10.1016/j.cmpb.2013.05.020. Epub 2013 Jul 18.

Supplemental Content

Loading ...
Support Center